Colossal Biosciences
At Colossal Biosciences, we endeavor to jumpstart nature’s ancestral heartbeat
Colossal will revolutionize history and be the first company to use CRISPR technology successfully in the de-extinction of previously lost species. On the journey we will build radical new software tools and technologies to advance the science of genomics overall. At Colossal Biosciences, we endeavor to jumpstart nature’s ancestral heartbeat. To see the woolly mammoth thunder upon the tundra once again. To advance the economics of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet can breathe easier. These things, which were not achievable before, are now. In our laboratories. Through our breakthroughs in CRISPR and genetic engineering. We are leading the new charge of bioscience. We accept the responsibility. And we can see the light at the end of it all.
- Sector
- Travel & Tourism, Genetics & Genomics, Media & Entertainment
- Based in
- Dallas, Austin
- Founded
- 2021
- Team
- 170
- Backed by
- Texas Fund I
In the news
Colossal Biosciences raises $120M to revive the Dodo bird and other extinct species, hits $10.3B valuation
The dodo bird, last seen in the 17th century before Dutch sailors hunted it into oblivion, may soon waddle its way back into existence. Dallas-based Colossal Biosciences has secured an extra $120 million to push forward its headline-grabbing de-extinction projects—most famously, the resurrection of the dodo. The funding extends the company’s Series C round to
Texas Fund I
The Return of the Dire Wolf
Colossal Biosciences has genetically engineered the first dire wolf to live in over 10,000 years. Here's what that means for other extinct species.
Texas Fund I
Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths
Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.
Texas Fund I
Chicks hatch from artificial egg as biotech company aims to revive extinct species
Colossal Biosciences said over two dozen healthy baby chickens have hatched from an artificial egg platform it launched as a part of an effort to revive a large flightless bird that went extinct centuries ago.
Texas Fund I
Colossal Biosciences Hatches First Chicks from Its Fully Artificial Egg System
/PRNewswire/ -- Colossal Biosciences, the world
Texas Fund I
Colossal Biosciences is growing chickens in a 3D-printed artificial eggshell
In an early step towards artificial wombs, a biotech company claims it’s developed a “fully artificial” chicken egg.
Texas Fund I